These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-selectivity profiling of released and labeled N-glycans via polar-embedded reversed-phase chromatography. Wilhelm JG; Dehling M; Higel F Anal Bioanal Chem; 2019 Jan; 411(3):735-743. PubMed ID: 30478517 [TBL] [Abstract][Full Text] [Related]
3. Glycine additive facilitates site-specific glycosylation profiling of biopharmaceuticals by ion-pairing hydrophilic interaction chromatography mass spectrometry. Zhao Y; Raidas S; Mao Y; Li N Anal Bioanal Chem; 2021 Feb; 413(5):1267-1277. PubMed ID: 33244686 [TBL] [Abstract][Full Text] [Related]
5. Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins. Shang TQ; Saati A; Toler KN; Mo J; Li H; Matlosz T; Lin X; Schenk J; Ng CK; Duffy T; Porter TJ; Rouse JC J Pharm Sci; 2014 Jul; 103(7):1967-1978. PubMed ID: 24840237 [TBL] [Abstract][Full Text] [Related]
6. Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants. Triguero A; Cabrera G; Royle L; Harvey DJ; Rudd PM; Dwek RA; Bardor M; Lerouge P; Cremata JA Anal Biochem; 2010 May; 400(2):173-83. PubMed ID: 20109437 [TBL] [Abstract][Full Text] [Related]
7. Small scale affinity purification and high sensitivity reversed phase nanoLC-MS N-glycan characterization of mAbs and fusion proteins. Higel F; Seidl A; Demelbauer U; Sörgel F; Frieß W MAbs; 2014; 6(4):894-903. PubMed ID: 24848368 [TBL] [Abstract][Full Text] [Related]
8. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods. Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M MAbs; 2015; 7(4):732-42. PubMed ID: 25996192 [TBL] [Abstract][Full Text] [Related]
9. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals. Melmer M; Stangler T; Schiefermeier M; Brunner W; Toll H; Rupprechter A; Lindner W; Premstaller A Anal Bioanal Chem; 2010 Sep; 398(2):905-14. PubMed ID: 20640408 [TBL] [Abstract][Full Text] [Related]
10. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods. Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M MAbs; 2015; 7(1):167-79. PubMed ID: 25524468 [TBL] [Abstract][Full Text] [Related]
11. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody. Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652 [TBL] [Abstract][Full Text] [Related]
12. Comparison of ZIC-HILIC and graphitized carbon-based analytical approaches combined with exoglycosidase digestions for analysis of glycans from monoclonal antibodies. Mauko L; Lacher NA; Pelzing M; Nordborg A; Haddad PR; Hilder EF J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():93-104. PubMed ID: 23217312 [TBL] [Abstract][Full Text] [Related]
13. Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis. Hilliard M; Alley WR; McManus CA; Yu YQ; Hallinan S; Gebler J; Rudd PM MAbs; 2017; 9(8):1349-1359. PubMed ID: 28895795 [TBL] [Abstract][Full Text] [Related]
14. HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases. Messina A; Palmigiano A; Esposito F; Fiumara A; Bordugo A; Barone R; Sturiale L; Jaeken J; Garozzo D Glycoconj J; 2021 Apr; 38(2):201-211. PubMed ID: 32915358 [TBL] [Abstract][Full Text] [Related]
15. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis. D'Atri V; Fekete S; Beck A; Lauber M; Guillarme D Anal Chem; 2017 Feb; 89(3):2086-2092. PubMed ID: 28208257 [TBL] [Abstract][Full Text] [Related]
16. Identification of Low Abundant Isomeric N-Glycan Structures in Biological Therapeutics by LC/MS. Zhao J; Li S; Li C; Wu SL; Xu W; Chen Y; Shameem M; Richardson D; Li H Anal Chem; 2016 Jul; 88(14):7049-59. PubMed ID: 27291648 [TBL] [Abstract][Full Text] [Related]
17. Ion-pair reversed-phase high performance liquid chromatography method for the quantification of isoaspartic acid in a monoclonal antibody. Kern W; Mende R; Denefeld B; Sackewitz M; Chelius D J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():26-33. PubMed ID: 24631807 [TBL] [Abstract][Full Text] [Related]
18. High sensitivity acidic N-glycan profiling with MS-enhancing derivatization and mixed mode chromatography. Liu X; Wang Q; Lauber MA J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Feb; 1191():123120. PubMed ID: 35091294 [TBL] [Abstract][Full Text] [Related]
19. Site-specific protein glycosylation analysis with glycan isomer differentiation. Hua S; Nwosu CC; Strum JS; Seipert RR; An HJ; Zivkovic AM; German JB; Lebrilla CB Anal Bioanal Chem; 2012 May; 403(5):1291-302. PubMed ID: 21647803 [TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based glycoprofiling of biopharmaceuticals by using an automated data processing tool: SimGlycan Puranik A; Goswami R; Sutar P; Tupe D; Rasam P; Dandekar P; Jain R J Sep Sci; 2023 Feb; 46(3):e2200521. PubMed ID: 36463509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]